WhiteOak Capital Pharma And Heathcare Fund Regular Plan Growth
(Erstwhile WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth)
Fund House: WhiteOak Capital Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 06-02-2024 |
| Asset Class: Equity |
| Benchmark: BSE Healthcare TRI |
| TER: 2.8% As on (30-08-2026) |
| Status: Open Ended Schemes |
| Minimum Investment: 500.0 |
| Minimum Topup: 500.0 |
| Total Assets: 902.24 Cr As on 31-08-2026(Source:AMFI) |
| Turn over: 1.99% | Exit Load: Nil |
16.443
-0.06 (-0.3649%)
20.32%
Benchmark: 14.73%
PERFORMANCE
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Investment Objective
To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Current Asset Allocation (%)
Indicators
| Standard Deviation | - |
| Sharpe Ratio | - |
| Alpha | - |
| Beta | - |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
| Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
|---|---|---|---|---|---|---|
| WhiteOak Capital Pharma And Heathcare Fund Regular Plan Growth | 06-02-2024 | 20.04 | 12.38 | - | - | - |
Scheme Characteristics
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
40.31%
Others
6.36%
Large Cap
30.61%
Mid Cap
22.72%
